These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20566400)

  • 1. 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: Drug release, microstructure, and ex vivo permeation behaviors.
    Lei L; Liu X; Guo S; Tang M; Cheng L; Tian L
    J Control Release; 2010 Aug; 146(1):45-53. PubMed ID: 20566400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amphiphilic PCL-PEG-PCL copolymer addition on 5-fluorouracil release from biodegradable PCL films for stent application.
    Lu F; Lei L; Shen YY; Hou JW; Chen WL; Li YG; Guo SR
    Int J Pharm; 2011 Oct; 419(1-2):77-84. PubMed ID: 21803141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zero-order release of 5-fluorouracil from PCL-based films featuring trilayered structures for stent application.
    Lei L; Liu X; Shen YY; Liu JY; Tang MF; Wang ZM; Guo SR; Cheng L
    Eur J Pharm Biopharm; 2011 May; 78(1):49-57. PubMed ID: 21255648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCL films incorporated with paclitaxel/5-fluorouracil: Effects of formulation and spacial architecture on drug release.
    Rong HJ; Chen WL; Guo SR; Lei L; Shen YY
    Int J Pharm; 2012 May; 427(2):242-51. PubMed ID: 22349052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective layer: in vitro release, permeation and mechanical properties.
    Guo Q; Guo S; Wang Z
    J Control Release; 2007 Apr; 118(3):318-24. PubMed ID: 17289208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on hydrophilic 5-fluorouracil release from hydrophobic poly(ε-caprolactone) cylindrical implants.
    Hou J; Li C; Cheng L; Guo S; Zhang Y; Tang T
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1068-75. PubMed ID: 21449700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatments of paclitaxel with poly(vinyl pyrrolidone) to improve drug release from poly(ɛ-caprolactone) matrix for film-based stent.
    Lu F; Shen YY; Shen YQ; Hou JW; Wang ZM; Guo SR
    Int J Pharm; 2012 Sep; 434(1-2):161-8. PubMed ID: 22643225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
    Papadimitriou S; Bikiaris D
    J Control Release; 2009 Sep; 138(2):177-84. PubMed ID: 19446585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends.
    Cheng L; Lei L; Guo S
    Int J Pharm; 2010 Mar; 387(1-2):129-38. PubMed ID: 20005928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
    Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
    Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release.
    Tang M; Hou J; Lei L; Liu X; Guo S; Wang Z; Chen K
    Int J Pharm; 2010 Nov; 400(1-2):66-73. PubMed ID: 20804834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.
    Yan S; Zhu J; Wang Z; Yin J; Zheng Y; Chen X
    Eur J Pharm Biopharm; 2011 Aug; 78(3):336-45. PubMed ID: 21195174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of the macroporosity of polycaprolactone-based biocomposites and release kinetics for drug delivery.
    Wang Y; Chang HI; Wertheim DF; Jones AS; Jackson C; Coombes AG
    Biomaterials; 2007 Nov; 28(31):4619-27. PubMed ID: 17659772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of sirolimus from a multilayered PLGA stent matrix.
    Wang X; Venkatraman SS; Boey FY; Loo JS; Tan LP
    Biomaterials; 2006 Nov; 27(32):5588-95. PubMed ID: 16879865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
    Li XN; Guo HX; Heinamaki J
    J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible photocrosslinked poly(ester anhydride) based on functionalized poly(epsilon-caprolactone) prepolymer shows surface erosion controlled drug release in vitro and in vivo.
    Mönkäre J; Hakala RA; Vlasova MA; Huotari A; Kilpeläinen M; Kiviniemi A; Meretoja V; Herzig KH; Korhonen H; Seppälä JV; Järvinen K
    J Control Release; 2010 Sep; 146(3):349-55. PubMed ID: 20558218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff.
    Pires NM; van der Hoeven BL; de Vries MR; Havekes LM; van Vlijmen BJ; Hennink WE; Quax PH; Jukema JW
    Biomaterials; 2005 Sep; 26(26):5386-94. PubMed ID: 15814137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic erosion of bioartificial membranes to control drug delivery.
    Coluccio ML; Ciardelli G; Bertoni F; Silvestri D; Cristallini C; Giusti P; Barbani N
    Macromol Biosci; 2006 Jun; 6(6):403-11. PubMed ID: 16775815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.